The SPR collaboration has added aspirin to its covid early treatment protocol. New studies have confirmed a strong antiplatelet and anticoagulant effect of aspirin in covid patients (i.e. reducing platelet hyper-reactivity, see figure below), which may help prevent major covid complications such as thrombosis, lung embolism and strokes in high-risk patients. Continue reading →
Source